EPHA2 and cancer: EphA2-targeted nanoparticles are, in most cases, liposomes, i.e., spherical vesicles with a lipid bilayer that can be loaded with small interfering RNAs (siRNAs) or drugs for targeted delivery to cancer cells, or polymeric nanoparticles made from biodegradable polymers [108,109].